RIG-I-deficient mice are protected against IL-23- and imiquimod-induced psoriasiform disease [57] and injection of RIG-I ligand 5′ppp-dsRNA to the ear of wild-type mice facilitates IL-23-mediated psoriasis-like skin inflammation in mice [57]. Here, RIGI is linked to psoriasis.